S2 Fig - by Octavio A. C. Talyuli (4285141)

A) illustration of horizontal and diagonal flight initiation distances (FID) in meters, in addition to altitude in meters in a hypothetical colony. by Estefania Velilla (22566709)

Relative fixation duration distribution. by Junhui Kim (18575083)

Relative saccade amplitude distribution. by Junhui Kim (18575083)

HPx1 expression is controlled by dietary heme and the E75 transcription factor. by Octavio A. C. Talyuli (4285141)

Endogenous S100A8/A9 is involved in cellular proliferation. by Guergana Iotzova-Weiss (712793)

“…A decrease of the proliferation rate was detected (20–30%) based on the BrdU incorporation (t-test *p = 0.002). …”

Funnel plots of studies included in the meta-analysis assessing by Solima Sabeel (9545738)

Fig 6 - by Kellie J. Walters (10451329)

Fig 1 - by Junhui Kim (18575083)

Fig 1 - by Kellie J. Walters (10451329)

EZH2 and HDAC inhibitors cooperatively derepress a subset of PRC2 targets in CRPC. by Amy E. Schade (15368259)

Data of research. by Natália de Souza Duarte (18264611)

“…The root mean square of a 5-second contraction period, peak root mean square values, area values, % maximal voluntary contraction (root mean square normalized by peak signal), and median frequency were collected. …”

Sample characterization (n = 30). by Natália de Souza Duarte (18264611)

“…The root mean square of a 5-second contraction period, peak root mean square values, area values, % maximal voluntary contraction (root mean square normalized by peak signal), and median frequency were collected. …”

Flowchart of sample eligibility. by Natália de Souza Duarte (18264611)

“…The root mean square of a 5-second contraction period, peak root mean square values, area values, % maximal voluntary contraction (root mean square normalized by peak signal), and median frequency were collected. …”

Fig 8 - by Junhui Kim (18575083)

Fig 3 - by Kellie J. Walters (10451329)

Fig 8 - by Kellie J. Walters (10451329)

Fig 5 - by Kellie J. Walters (10451329)

Overall analysis of randomized controlled trials. by Solima Sabeel (9545738)

“…Notably, atorvastatin demonstrated the most significant reduction in IL-6 and TNF-α levels, while fluvastatin and rosuvastatin displayed the greatest impact on decreasing CRP and LDL-C levels, respectively. Stratification by a longer treatment duration of more than four months revealed that atorvastatin achieved the most significant reduction in IL-6 and TNF-α. …”

Newcastle-Ottawa scale. by Solima Sabeel (9545738)

“…Notably, atorvastatin demonstrated the most significant reduction in IL-6 and TNF-α levels, while fluvastatin and rosuvastatin displayed the greatest impact on decreasing CRP and LDL-C levels, respectively. Stratification by a longer treatment duration of more than four months revealed that atorvastatin achieved the most significant reduction in IL-6 and TNF-α. …”